Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

REVCO AUTHORIZING CMTE. TO IMPROVE CHAIN's PURCHASING PROCEDURES

Executive Summary

REVCO AUTHORIZING CMTE. TO IMPROVE CHAIN's PURCHASING PROCEDURES, the company stated in a Sept. 7 press release.Revco said a special cmte. of outside directors, which was appointed in July to investigate allegations about the chain's purchasing practices, has been authorized by the board to "continue to work with management consultants from Peat, Marwick, Mitchell & Co. in developing a program for continuing improvement in purchasing department procedures and policies and closer coordination with other departments." Revco's board also approved plans proposed by VP-merchandising and purchasing Daniel Horowitz for purchasing improvements. The cmte. found that there had been "inadequate procedures and practices within the purchasing department" which "contributed to some purchasing mistakes," the release said. The group also identified a "lack of coordination between the purchasing of promotional goods and regular inventory, scheduling difficulties for promotional items with related advertising circulars, weakness in verification of certain purchase order quantities with quantities actually delivered, timing of deliveries for some seasonal goods, and coordination among purchasing, store operations and warehouses." The cmte. concluded, however, that the "specific allegations" made by Odd Lot subsidiary officials Isaac Perlmutter and Bernard Marden were "in many cases insignificant, contained extensive errors factually, and in large part dealt with matters where business judgment could have gone either way at the time the decision was made." None of the allegations have had "a material financial (BRACKET)effect(BRACKET) on the company," the cmte. said. The board approved the transfer of purchasing responsibility from Elliot Dworkin, now VP-marketing, to Horowitz. Revco merged merchandising and purchasing responsibilities under Horowitz in August. The board also approved Revco's decision to terminate further purchasing through Joseph DeKama.

You may also be interested in...



Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance

FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials

Shire Hopes To Sow Future Deals With $50M Venture Fund

Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth

UsernamePublicRestriction

Register

OM007466

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel